PS

Peter Sande

CEO

Synaffix BV

Eindhoven, North Brabant


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Synaffix BV
Industry
research
Employees
56.0
Seniority
C suite
Annual Revenue
6000000.0
Latest Funding
Series A

Technologies

Outlook Blue Host Marketo Google Font API Google Maps (Non Paid Users) Google Maps Mobile Friendly WordPress.org Nginx Google Tag Manager

Keywords

antibodydrug conjugates cell engagers targeted gene therapy bispecific antibodies biotechnology research adc antibody-drug conjugates glycan technology metal-free click chemistry targeted delivery therapeutic payloads conjugation technology toxsyn linker-payloads glycoconnect immune cell engagers protein conjugation clinical-stage platform therapeutic candidates biotech collaboration cancer therapeutics drug-antibody ratio therapeutic efficacy tolerability targeted cancer therapies protein-based payloads next-generation adcs scfv fab cytokines nk cell recruitment preclinical development phase 1 phase 2 phase 3 oncology pipeline immune cell recruitment biologic treatments custom payloads drug development clinical trial targeted therapeutics partner pipeline internal pipelines technology licensing research collaborations in vivo data research innovators clinical data proprietary technology drug design disease targeting cancer treatment specialized payloads high unmet medical need

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans